4//SEC Filing
Jaen Juan C. 4
Accession 0001724521-24-000062
CIK 0001724521other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:55 PM ET
Size
7.9 KB
Accession
0001724521-24-000062
Insider Transaction Report
Form 4
Jaen Juan C.
President
Transactions
- Sale
Common Stock
2024-02-26$20.06/sh−3,900$78,234→ 1,211,365 total(indirect: By Trust) - Sale
Common Stock
2024-02-27$20.10/sh−23,132$464,953→ 1,188,233 total(indirect: By Trust)
Holdings
- 341,475
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2023.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001422996
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:55 PM ET
- Size
- 7.9 KB